K Rebolledo-Ponietsky1, C V Munayco1,2, E Mezones-Holguín1,3. 1. School of Medicine, Universidad Peruana de Ciencias Aplicadas-UPC, Lima, Peru. 2. National Center for Epidemiology, Disease Prevention and Control, Ministry of Health, Lima, Peru. 3. Epi-Gnosis Solutions, Piura, Peru.
Authors: Alfonso J Rodríguez-Morales; D Katterine Bonilla-Aldana; Miguel Morales; José A Suárez; Ernesto Martínez-Buitrago Journal: Ann Clin Microbiol Antimicrob Date: 2019-03-08 Impact factor: 3.944